49 related articles for article (PubMed ID: 21276760)
1. Treatment of chronic hepatitis B: update of the recommendations from the 2007 Italian Workshop.
Carosi G; Rizzetto M; Alberti A; Cariti G; Colombo M; Craxì A; Filice G; Levrero M; Mazzotta F; Pastore G; Piccinino F; Prati D; Raimondo G; Sagnelli E; Toti M; Brunetto M; Bruno R; Di Marco V; Ferrari C; Gaeta GB; Lampertico P; Marzano A; Pollicino T; Puoti M; Santantonio T; Smedile A
Dig Liver Dis; 2011 Apr; 43(4):259-65. PubMed ID: 21276760
[TBL] [Abstract][Full Text] [Related]
2. [Therapy of chronic hepatitis B. Tenofovir--first choice in current EASL guidelines].
MMW Fortschr Med; 2009 May; 151(22):38-9. PubMed ID: 19526965
[No Abstract] [Full Text] [Related]
3. Treatment of chronic hepatitis B virus infection - Dutch national guidelines.
Buster EH; van Erpecum KJ; Schalm SW; Zaaijer HL; Brouwer JT; Gelderblom HC; de Knegt RJ; Minke Bakker C; Reesink HW; Janssen HL;
Neth J Med; 2008; 66(7):292-306. PubMed ID: 18663260
[TBL] [Abstract][Full Text] [Related]
4. Treatment of chronic hepatitis B: recommendations from an Italian workshop.
Carosi G; Rizzetto M
Dig Liver Dis; 2008 Aug; 40(8):603-17. PubMed ID: 18499540
[TBL] [Abstract][Full Text] [Related]
5. Tenofovir disoproxil fumarate in the treatment of chronic hepatitis B.
Jenh AM; Pham PA
Expert Rev Anti Infect Ther; 2010 Oct; 8(10):1079-92. PubMed ID: 20954872
[TBL] [Abstract][Full Text] [Related]
6. Improvements in parameters of end-stage liver disease in patients with HIV/HBV-related cirrhosis treated with tenofovir.
Matthews GV; Cooper DA; Dore GJ
Antivir Ther; 2007; 12(1):119-22. PubMed ID: 17503756
[TBL] [Abstract][Full Text] [Related]
7. Reversibility of cirrhosis in HIV/HBV coinfection.
Mallet VO; Dhalluin-Venier V; Verkarre V; Correas JM; Chaix ML; Viard JP; Pol S
Antivir Ther; 2007; 12(2):279-83. PubMed ID: 17503671
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcome of tenofovir disoproxil fumarate use against hepatitis B in an HIV-coinfected cohort.
Alvarez-Uria G; Ratcliffe L; Vilar J
HIV Med; 2009 May; 10(5):269-73. PubMed ID: 19210695
[TBL] [Abstract][Full Text] [Related]
9. Treatment of HBV-related cirrhosis.
Vallet-Pichard A; Mallet V; Costentin CE; Pol S
Expert Rev Anti Infect Ther; 2009 Jun; 7(5):527-35. PubMed ID: 19485793
[TBL] [Abstract][Full Text] [Related]
10. What is the optimal therapy for chronic hepatitis B?
Lyra AC; Di Bisceglie AM
Minerva Med; 2001 Dec; 92(6):431-4. PubMed ID: 11740431
[TBL] [Abstract][Full Text] [Related]
11. Antiviral therapy for hepatitis B virus-related decompensated cirrhosis.
Wang JY
J Dig Dis; 2012 Nov; 13(11):555-7. PubMed ID: 23107441
[TBL] [Abstract][Full Text] [Related]
12. Combination of tenofovir and lamivudine versus tenofovir after lamivudine failure for therapy of hepatitis B in HIV-coinfection.
Schmutz G; Nelson M; Lutz T; Sheldon J; Bruno R; von Boemmel F; Hoffmann C; Rockstroh J; Stoehr A; Wolf E; Soriano V; Berger F; Berg T; Carlebach A; Schwarze-Zander C; Schürmann D; Jaeger H; Mauss S
AIDS; 2006 Oct; 20(15):1951-4. PubMed ID: 16988516
[TBL] [Abstract][Full Text] [Related]
13. Timing of hepatitis C antiviral therapy in patients with advanced liver disease: a decision analysis model.
Saab S; Hunt DR; Stone MA; McClune A; Tong MJ
Liver Transpl; 2010 Jun; 16(6):748-59. PubMed ID: 20517909
[TBL] [Abstract][Full Text] [Related]
14. Tenofovir disoproxil fumarate therapy for chronic hepatitis B in human immunodeficiency virus/hepatitis B virus-coinfected individuals for whom interferon-alpha and lamivudine therapy have failed.
Ristig MB; Crippin J; Aberg JA; Powderly WG; Lisker-Melman M; Kessels L; Tebas P
J Infect Dis; 2002 Dec; 186(12):1844-7. PubMed ID: 12447773
[TBL] [Abstract][Full Text] [Related]
15. Effect of long-term lamivudine in chronic hepatitis B virus-infected children.
Ozgenç F; Arikan C; Sertoz RY; Nart D; Aydogdu S; Yagci RV
Antivir Ther; 2004 Oct; 9(5):729-32. PubMed ID: 15535410
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of adjuvant treatment after curative treatment in patients with HBV related hepatocellular carcinoma].
Hagiwara S; Kudo M
Nihon Rinsho; 2011 May; 69 Suppl 4():546-50. PubMed ID: 22096978
[No Abstract] [Full Text] [Related]
17. Expert recommendations on the application of interferon for chronic hepatitis B.
Wan MB; Weng XH
J Dig Dis; 2013 Dec; 14(12):626-37. PubMed ID: 23981279
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis B Recommendations Updated.
Kuehn BM
JAMA; 2018 Feb; 319(8):762. PubMed ID: 29486046
[No Abstract] [Full Text] [Related]
19. Management and Treatment of Patients with Chronic Hepatitis B: Towards Personalized Medicine.
Colombatto P; Coco B; Bonino F; Brunetto MR
Viruses; 2022 Mar; 14(4):. PubMed ID: 35458431
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of a Hepatitis B Surface Antigen-Based Model for the Prediction of Functional Cure in Patients with Chronic Hepatitis B Virus Infection Treated with Nucleos(t)ide Analogues: A Real-World Study.
Caviglia GP; Troshina Y; Garro E; Gesualdo M; Aneli S; Birolo G; Pittaluga F; Cavallo R; Saracco GM; Ciancio A
J Clin Med; 2021 Jul; 10(15):. PubMed ID: 34362093
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
